1. Fachinformation: Losartan-AbZ 100 mg Filmtabletten. https://www.abz.de/assets/products/de/label/Losartan-AbZ%20100%20mg%20Filmtabletten%20-%203.pdf?pzn=9154992. Accessed November 28, 2023.
2. World Health Organization. Model List of Essential Medicines. 2021;22nd List. https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02. Accessed November 28, 2023.
3. European Medicines Agency. EMA reviewing medicines containing valsartan from Zhejiang Huahai following detection of an impurity. (July 5, 2018). https://www.ema.europa.eu/en/documents/press-release/ema-reviewing-medicines-containing-valsartan-zhejiang-huahai-following-detection-impurity_en.pdf. Accessed November 28, 2023.
4. European Medicines Agency: Valsartan. review of impurities extended to other sartan medicines. (September 21, 2018). https://www.ema.europa.eu/en/documents/press-release/valsartan-review-impurities-extended-other-sartan-medicines_en.pdf. Accessed November 28, 2023.
5. Co-ordination Group for Mutual Recognition and Decentralised Procedures-Human. Risk of azido-impurity in losartan-containing medicinal products. (September 23, 2021). https://www.bfarm.de/SharedDocs/Downloads/DE/Arzneimittel/Pharmakovigilanz/PSUSAS/m-r/octreotid_cmdh_Anlage-3.pdf?__blob=publicationFile. Accessed November 28, 2023.